<DOC>
	<DOCNO>NCT00671398</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy Ramelteon , daily ( QD ) , healthy subject within sleep lab .</brief_summary>
	<brief_title>Efficacy Ramelteon Transient Insomnia Healthy Adults</brief_title>
	<detailed_description>Insomnia characterize difficulty initiate maintain sleep , non-restorative non-refreshing sleep . Transient insomnia affect approximately one-third one-half US population , base result 2 survey representative sample adult US population conduct Gallup Organization respondent ask `` ever difficulty sleep . '' Based report `` regular '' `` frequent '' sleep difficulty , result study suggest approximately one-tenth US population experience chronic insomnia . The ideal treatment insomnia would reduce latency onset sleep increase total sleep time , without negative impact sleep architecture without safety concern next-day effect . Ramelteon selective melatonin-1 receptor agonist global development Takeda Chemical Industries , Ltd. , treatment transient chronic insomnia treatment Circadian Rhythm Sleep Disorders . This study conduct evaluate safety efficacy single dose Ramelteon normal healthy subject sleep lab model transient insomnia . Participation study anticipate 3 week .</detailed_description>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<criteria>Inclusion Criteria Females childbearing potential sexually active must agree use adequate contraception , neither pregnant lactating Screening throughout duration study . Habitual bedtime 8:30 p.m. 12:00 a.m. Sleeps 6.5 8 hour per night subjective sleep latency less equal 30 minute . Body mass index 18 34 , inclusive . Any history insomnia . Spent one night sleep laboratory . Epworth Sleepiness Scale score great 10 . Known hypersensitivity Ramelteon related compound , include melatonin . Previously participate study involve Ramelteon . Participated investigational study and/or take investigational drug within 30 day five halflives prior Day 1 , whichever longer . Sleep schedule change require employment ( ie , shift work ) within three month precede Day 1 fly across great three time zone within seven day prior screen . Participated weight loss program substantially alter exercise routine within 30 day prior Day 1 . History seizure , sleep apnea , chronic obstructive pulmonary disease , restless leg syndrome , schizophrenia , bipolar disorder , mental retardation , cognitive disorder . History psychiatric disorder ( include anxiety depression ) within past 12 month . History drug addiction drug abuse within past 12 month . Any physical psychiatric disorder may associate sleep disturbance . History alcohol abuse within past 12 month , define Diagnostic Statistical Manual Mental Disorders , 4th Edition Revised and/or regularly consume 4 alcoholic drink per day . Current significant neurological , hepatic , renal , endocrine , cardiovascular , gastrointestinal , pulmonary , hematologic metabolic disease . Uses tobacco product nightly awakening . Any clinically important abnormal finding determine medical history , physical examination , electrocardiogram , clinical laboratory test , determine investigator . Positive hepatitis panel . Positive urine drug screen include alcohol screen positive breathalyzer test checkin . Any additional condition ( ) investigator 's opinion would affect sleepwake function prohibit subject complete study best interest subject . Is required take continue take disallow medication , prescription medication , herbal treatment overthe counter medication , include : Anxiolytics Hypnotics Antidepressants Anticonvulsants Sedating H1 antihistamine Systemic steroid Respiratory stimulant ( eg , theophylline ) Decongestants Overthecounter prescription stimulant Overthecounter prescription diet aids Central nervous system active drug Narcotic analgesic All beta blocker St. John 's Wort Kavakava gingko biloba</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Insomnia</keyword>
	<keyword>Sleep Disorder</keyword>
	<keyword>Drug Therapy</keyword>
</DOC>